# Qingsong Liu

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/qingsong-liu/

## Facts

| Field | Value |
| --- | --- |
| Citations | 20,925 |
| Field | Lung Cancer Treatments and Mutations |
| h-index | 55 |
| i10-index | 210 |
| Last Known Institution | University of Science and Technology of China |
| OpenAlex ID | https://openalex.org/A5112066295 |
| ORCID iD | https://orcid.org/0000-0002-7829-2547 |
| Works | 436 |

## Researcher papers

- [Systematic identification of genomic markers of drug sensitivity in cancer cells](https://scholariq.org/papers/systematic-identification-of-genomic-markers-of-drug-sensitivity-in-cancer-cells/)
- [Exploration of Type II Binding Mode: A Privileged Approach for Kinase Inhibitor Focused Drug Discovery?](https://scholariq.org/papers/exploration-of-type-ii-binding-mode-a-privileged-approach-for-kinase-inhibitor/)
- [Metabolic and Functional Genomic Studies Identify Deoxythymidylate Kinase as a Target in <i>LKB1</i> -Mutant Lung Cancer](https://scholariq.org/papers/metabolic-and-functional-genomic-studies-identify-deoxythymidylate-kinase-as-a/)

## Researcher topics

- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)
- [RNA modifications and cancer](https://scholariq.org/topics/rna-modifications-and-cancer/)
- [PI3K/AKT/mTOR signaling in cancer](https://scholariq.org/topics/pi3k-akt-mtor-signaling-in-cancer/)
- [Chronic Myeloid Leukemia Treatments](https://scholariq.org/topics/chronic-myeloid-leukemia-treatments/)
- [Chronic Lymphocytic Leukemia Research](https://scholariq.org/topics/chronic-lymphocytic-leukemia-research/)

## Researcher university

- [University of Science and Technology of China](https://scholariq.org/institutions/university-of-science-and-technology-of-china/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.